Keyword: CHMP recommendation
Check out Friday's dose of biotech's news of note.
Aveo Pharmaceuticals’ troubled tivozanib is on the cusp of winning approval in Europe, sending its stock on a tear.
EMA's drug approval committee has indicated it is likely to reject XBiotech’s metastatic colorectal cancer candidate.
The European Medicines Agency has recommended the approval of Blue Earth Diagnostics’ prostate cancer PET imaging agent.
The European Medicines Agency has started a review of medicines whose studies have been conducted at either of the two sites of Micro Therapeutic Research Labs in India, following concerns about the CRO's data integrity.